Aurora Cannabis Reports Positive Free Cash Flow for Q1 FY25

TL;DR

Aurora Cannabis hit positive free cash flow in Q1 FY25, a big win for the company.

AI Summary

Aurora Cannabis Inc. announced its fiscal 2025 first quarter results on August 7, 2024, highlighting positive free cash flow. The company, led by CEO Miguel Martin, is incorporated in Canada and operates in the medicinal chemicals and botanical products sector.

Why It Matters

Achieving positive free cash flow is a significant milestone for Aurora Cannabis, indicating improved financial health and operational efficiency.

Risk Assessment

Risk Level: medium — The cannabis industry is subject to significant regulatory and market volatility, which can impact financial performance.

Key Numbers

• Positive Free Cash Flow — Financial Metric (Indicates improved financial health for Q1 FY25)

Key Players & Entities

• Aurora Cannabis Inc. (company) — Registrant
• Miguel Martin (person) — Chief Executive Officer
• August 7, 2024 (date) — Announcement Date
• Fiscal 2025 First Quarter (date) — Reporting Period

FAQ

From the Filing

0001279569-24-000970.txt : 20240807 0001279569-24-000970.hdr.sgml : 20240807 20240807071923 ACCESSION NUMBER: 0001279569-24-000970 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20240807 FILED AS OF DATE: 20240807 DATE AS OF CHANGE: 20240807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AURORA CANNABIS INC CENTRAL INDEX KEY: 0001683541 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38691 FILM NUMBER: 241181433 BUSINESS ADDRESS: STREET 1: 2207 90B STREET SW CITY: EDMONTON STATE: A0 ZIP: T6X 1V8 BUSINESS PHONE: 604-362-5207 MAIL ADDRESS: STREET 1: 409 GRANVILLE STREET STREET 2: SUITE 1700 CITY: VANCOUVER STATE: A1 ZIP: V6C 1T2 6-K 1 aurora_6k.htm FORM 6-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of August 2024 Commission File No. 001-38691 AURORA CANNABIS INC. (Translation of registrant's name into English) 2207 90B St. SW Edmonton, Alberta T6X 1V8 Canada (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F Form 20-F ☐ Form 40-F ☒ SUBMITTED HEREWITH Exhibits Description 99.1 News Release dated August 7, 2024 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. AURORA CANNABIS INC. /s/ Miguel Martin Miguel Martin Chief Executive Officer Date: August 7, 2024 EX-99.1 2 ex991.htm NEWS RELEASE DATED AUGUST 7, 2024 Exhibit 99.1 Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow Delivers Positive Free Cash Flow 1 of $6.5 Million Increases Total Quarterly Net Revenue 1 by 12% YoY to $83.4 Million, Record Net Revenue 1 of $47.2 Million in Global Medical Cannabis Generates Adjusted EBITDA 1 of $4.9 Million, a YoY increase of 87% Ends the Fiscal Quarter with a Debt-Free Cannabis Business 2 and a Cash Position of ~$182 Million EDMONTON, AB, Aug. 7, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora" ) (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter fiscal 2025. "This was a milestone quarter for Aurora, as we delivered strong net revenue 1 growth, a substantial increase in adjusted EBITDA 1 , and positive free cash flow 1 . Our impressive performance was driven by record net revenue 1 in the rapidly growing global medical cannabis segment, and we look forward to building on our achievements in key markets such as Germany, Australia, and the UK throughout fiscal 2025 and beyond. The quarter was further supported by a record contribution from our Bevo plant propagation business, underscoring the strength of our diversified business model," said Chief Executive Officer Miguel Martin. "The progress we made during the quarter sets a strong foundation for the rest of the fiscal year, and with our continued commitment to operational excellence and strategic growth, we are well-positioned to sustain this positive momentum. Our growth in global medical, the highest margin cannabis segment, alongside our strong balance sheet and ongoing fiscal discipline, are pivotal as we build on our achievement with respect to positive free cash flow," Mr. Martin concluded. 1 This press release includes certain non-GAAP financial measures, which are intended to supplement, not substitute for, comparable GAAP financial measures. See "Non-GAAP Measures" below for reconciliations of non-GAAP financ